The firm is the nation’s recognized leader in lawsuits against the makers of so-called Low T drugs, and was the first to file testosterone-related cases in Philadelphia.
If you have used or are currently taking testosterone therapy and have suffered a serious cardiovascular event such as a stroke, blood clot in the lungs (pulmonary embolism), blood clot in the deep veins (deep vein thrombosis), or heart attack, you may consider filing a testosterone class action lawsuit.
The firm is currently reviewing many additional injuries reported by other men across the U.S. and plans to bring other testosterone lawsuits against pharmaceutical makers in the near future.
Testosterone and Low-T Drugs Under Investigation
- AndroGel - Manufactured by AbbVie
- AndroDerm - Manufactured by Actavis
- Axiron - Manufactured by Eli Lilly and Company
- Bio-T-Gel - Manufactured by Teva Pharmaceuticals
- Fortesta - Manufactured by Endo Pharmaceuticals
- Striant - Manufactured by Columbia Laboratories
- Testim - Manufactured by Auxilium Pharmaceuticals
- Testopel - Manufactured by Auxilium Pharmaceuticals
- Delatestryl - Manufactured by Indevus Pharmaceuticals
- Depo-Testosterone - Manufactured by Pharmacia & Upjohn Company
Recent Studies Demonstrate Dangers of Testosterone Drugs
A 2014 medical study conducted by a team of leading researchers from UCLA and the U.S. National Cancer Institute found a two-fold increased risk of heart attacks in men 65 and older in the 90 days following the first prescription. That same study also showed adverse risks for men younger than 65 who had pre-existing cardiovascular disease. That group had a two- to three-fold increased risk of a heart attack in the 90 days following the first prescription. Read the study
A November 2013 study, conducted on older men in the U.S. Veterans Affairs health system, many of whom had underlying cardiovascular disease, demonstrated that there is a 30 percent increased risk of stroke, heart attack and death in the group that had been prescribed testosterone therapy drugs. The findings were reported in The Journal of the American Medical Association. Read the study
FDA Issues Safety Warning Regarding Testosterone Drugs and Low-T Therapies
In a bold, swift move responding to those studies, the U.S. Food and Drug Administration announced in January 2014 that it was reviewing the safety of testosterone replacement drugs. Federal regulators issued a medical safety alert warning men of the potentials risks and side effects of Low T therapies. In the alert, the FDA urged doctors to “consider whether the benefits of FDA-approved testosterone treatment are likely to exceed the potential risks of treatment.” Read the FDA Safety Alert
Low-T Prescriptions: Big Business for Big Pharma
The use of testosterone therapy drugs such as AndroGel, AndroDerm and others has skyrocketed in recent years with estimates suggesting that one in 25 men over the age of 60 now take them. According to industry analysts, sales of testosterone drugs could reach $5 billion by 2017.
Increased sales are due to aggressive ad campaigns by the pharmaceutical industry, which has marketed testosterone replacement therapies as a miracle drug to reverse naturally occurring, age-related conditions such as energy loss and reduced sex drive.
Time to Act is Now
Due to the life-threatening consequences of some forms of testosterone, lawyers from Ross Feller Casey are helping victims across the nation consider their legal options, possibly even filing testosterone lawsuits.
Ross Feller Casey has three Ivy League trained doctors right on staff, two of whom are also lawyers. This ideally positioned the firm to successfully litigate dangerous drug cases such as AndroGel lawsuits and those involving other testosterone therapies.
One of the firm’s doctor-lawyers, Dr. Mark A. Hoffman, has played a leading role in numerous successful pharmaceutical mass tort cases, and is a member of the American Association for Justice Testosterone Therapy Litigation Group.
Recently, Dr. Hoffman was appointed by a federal judge to the Plaintiffs Steering Committee (PSC) in the In re: Testosterone Replacement Therapy Multidistrict Litigation before the U.S. District Court for the Northern District of Illinois. This has been assigned all federal cases involving claims against the manufacturers of testosterone replacement therapies.
As a member of the PSC, Dr. Hoffman will play a leadership role in shaping plaintiff’s cases as the litigation progresses. He has also been selected as co-chair of the Science Committee and the State Coordinating Committee in the Multidistrict Litigation.
Are you wondering: How do I find a testosterone lawsuit lawyer near me?
If you or a loved one has suffered serious adverse medical effects after taking AndroGel or any other similar drug, please contact the Ross Feller Casey testosterone attorneys for a free case evaluation. Ross Feller Casey’s Low T lawyers handle cases, including testosterone therapy lawsuits, on a contingency basis, meaning that you will not pay anything unless we recover compensation on your behalf.
Testosterone Litigation in the News:
- Legal Journal reports that Ross Feller Casey files first testosterone lawsuit in Philadelphia - March 17, 2014
- Despite growing safety concerns, FDA approves Aveed, a new testosterone replacement drug - March 12, 2014
- Public Citizen petitions FDA for “black box” warnings on dangerous testosterone drugs - Feb. 26, 2014
- The New York Times Editorial Board: Overselling Testosterone, Dangerously - Feb. 4, 2014
- The New York Times OpEd: Don’t Ask Your Doctor About ‘Low T’ - Feb. 3, 2014